The Scale of Disruption

American biomedical research operates on a foundation of federal funding, primarily channeled through the National Institutes of Health. The NIH funds not only specific research projects but the infrastructure of American science itself: graduate students, postdoctoral researchers, laboratory technicians, shared facilities, and the institutional knowledge embedded in long-running research programs. When that funding is disrupted, the effects cascade in ways that are difficult to reverse.

A nationwide survey conducted by STAT News provides the most systematic portrait yet of what the Trump administration's funding disruptions have done to that foundation. The survey of nearly 1,000 NIH-funded researchers is not a collection of anecdotes or a tally of headlines. It is a structured assessment of how the past year of funding turmoil has actually changed research activity, employment, and the career decisions of the people who conduct American science.

The findings are severe. More than a quarter of respondents have laid off lab members—graduate students, postdocs, and staff who in many cases are at critical stages of their training or careers. More than two out of every five have canceled planned research projects. Two-thirds have counseled students to consider careers outside academic research. These numbers represent simultaneous disruption to both current scientific output and the pipeline of future scientists.

The Human Dimension

Behind each percentage point are individual trajectories. Graduate students who enrolled in doctoral programs expecting to complete their degrees are facing funding gaps that may force them to abandon their training mid-stream. Postdoctoral researchers—scientists who completed PhDs and are in the most intensive period of career development—are discovering that the lab positions supporting their progression into independent research no longer exist. Principal investigators who have spent decades building research programs around multi-year NIH grants are shutting down lines of inquiry that may not be restarted.

The career counseling finding is particularly significant. When senior scientists advise students to pursue careers outside academic research, they are drawing on their judgment about whether the system will be reliable enough to support those careers over the decade-plus horizon of scientific training. The fact that two-thirds of survey respondents are giving this advice suggests a widespread loss of confidence in the stability of federal research funding that goes beyond the immediate disruptions.

What Changed and When

The disruptions to NIH funding over the past year have taken several forms. The administration implemented indirect cost rate caps that reduced the overhead universities could charge on grants, effectively cutting the real value of existing awards. Grants in several research areas were terminated. The review and approval timelines for new grants lengthened as NIH staffing was reduced through voluntary separation incentives and other workforce reduction measures.

The indirect cost controversy generated the most immediate institutional conflict. Major research universities filed legal challenges that resulted in court orders temporarily blocking the caps. The legal battle continued through most of 2025 and into 2026, creating extended uncertainty about future funding even as individual researchers attempted to plan multi-year research programs.

Long-Term Consequences

The survey's most concerning finding may not be about current disruption but about the long-run trajectory of American scientific capacity. Scientific training is inherently a long-cycle process: producing an independent researcher capable of leading a research program typically takes fifteen to twenty years from the start of doctoral training. Disruptions to the pipeline today will reduce the capacity of American science a decade or more from now.

Several researchers surveyed noted that foreign students and researchers, who represent a significant fraction of the US biomedical workforce, are reconsidering whether to come to or remain in the United States. Academic and research institutions in Canada, the United Kingdom, Germany, and Australia have been actively recruiting American-trained researchers displaced or discouraged by funding instability. This international competition for scientific talent is intensifying precisely when American research institutions are offering less stability than they historically have.

The Economic Argument

NIH funding is an economic investment, not merely a scientific one. Every dollar of federal research funding generates economic activity through employment, procurement, and eventually through the commercial development of research findings into medical treatments, agricultural improvements, and technological applications. The pharmaceutical and biotechnology industries—among the most economically dynamic sectors of the American economy—are extensively dependent on the upstream basic research funded by NIH. Disrupting that pipeline imposes costs that will show up not in this fiscal year's budget but in the drug pipelines, diagnostic capabilities, and public health responses of the 2030s and beyond.

This article is based on reporting by STAT News. Read the original article.